Should Private Companies Be Allowed to Patent Genes? : The New Yorker

April 15, 2013 | By | Add a Comment

Today the Supreme Court will hear arguments answering the question–who should own your genes? More than 4,000 genes are covered by at least one US patent. This case, Association for Molecular Pathology v. Myriad Genetics, No. 12-398, explores our “genomic liberty” and will rule whether businesses can patent genes they find first. We’ll keep you posted as the story unfolds.

Should Private Companies Be Allowed to Patent Genes? : The New Yorker.

Filed in: Genetics

Leave a Reply

Trackback URL | RSS Feed for This Entry

You must be logged in to post a comment.